RADIANCE CED will collect real-world data and build on the existing safety and efficacy evidence for the company’s Paradise uRDN system.

The first-of-its-kind Paradise ultrasound renal denervation (uRDN) technology denervates the sympathetic nerves surrounding the renal arteries. This lowers blood pressure by reducing the overactivity that can lead to hypertension.

Paradise delivers two to three doses of 360-degree ultrasound energy, lasting seven seconds each. The energy travels through each of the main renal arteries to the surrounding nerves. Its catheter features the Recor HydroCooling system that circulates sterile water during the procedure to protect the renal artery wall.